MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617073413 A) filed by Eli Lilly And Company on June 12, 2026, for Compounds For The Treatment Of Diabetes Or Obesity.
Inventors include Abraham, Milata Mary; Alsina-Fernandez, Jorge; Hilliard, Darryl Wayne; Keyser, Samantha Grace Lyons; Liu, Wen Number; Qu, Hongchang; and Sluka, Kristi Lynn.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present disclosure relates to novel urocortin-2 polypeptides, having activity at the corticotropin-releasing hormone receptor-2 (CRHR2), pharmaceutical compositions comprising the polypeptides, and methods of using the polypeptides to treat disorders associated with CRHR2.
Disclaimer: Curated by HT Syndication.
